Creon (AbbVie Inc.)
Welcome to the PulseAid listing for the Creon drug offered from AbbVie Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AbbVie Inc. |
NON-PROPRIETARY NAME: | Pancrelipase |
SUBSTANCE NAME: | PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-04-30 |
END MARKETING DATE: | 0000-00-00 |
Creon HUMAN PRESCRIPTION DRUG Details:
Item Description | Creon from AbbVie Inc. |
LABELER NAME: | AbbVie Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 24000; 76000; 120000([USP’U]/1; [USP’U]/1; [USP’U]/1) |
START MARKETING DATE: | 2009-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0032-1224_c1fc1c81-d34a-7baf-ba5c-48425e015fe1 |
PRODUCT NDC: | 0032-1224 |
APPLICATION NUMBER: | NDA020725 |
Other PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE Pharmaceutical Manufacturers / Labelers: